BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Andor Release: Non-Invasive Quality Control of Cryopreserved Samples


3/12/2013 10:18:15 AM

12th February 2013, Belfast, UK: Since the dawn of modern medicine, human biological material has been collected, stored, and used for a variety of purposes with biological integrity ensured by cryopreservation at temperatures below -137°C. These samples are almost always unique and irreplaceable but, until now, it has been impossible to quality assure the material before use to check that thermal damage has not occurred.

In a recently published paper, a team from Saarland University's Biophysics and Cryotechnology department in Germany has demonstrated a powerful, Raman-scattering technique for monitoring and investigating cryopreserved samples. In particular, they confirmed unambiguously the detection of ice crystals in vitreous samples in situ at temperatures below -120°C. Known as devitrification and leading almost inevitably to loss of the complete sample, this is a common side effect of transient warming events, such as the clumsy withdrawal of neighbouring samples.

At the heart of their new probe is a fibre-borne imaging spectrograph from Andor, consisting of a Shamrock 303i imaging spectrograph with an iDus back-illuminated deep-depletion ('BR-DD') CCD camera. According to Professor Heiko Zimmermann who led the research, "We chose the rugged Andor iDus detector as it is rugged, established in spectroscopy and noted for its low light detection capability. We opted for the back-illuminated, deep-depletion chip in order to have access to longer illumination wavelength if cellular autofluorescence became an issue. The software supplied with the camera is very flexible and intuitive and we used the option to export the data to our bespoke software."

"Professor Zimmermann runs EuroCryo, Europe's largest research biobank and his work in detecting and monitoring changes in cryopreserved samples may be the first stage in establishing a recognised technique for retrospective proof of the absence of physical and chemical changes inside the sealed sample due to devitrification," says Antoine Varagnat, Product Specialist at Andor. "As this technique is, in principle, capable of detecting any other chemical change during storage, it is a powerful method for contactless monitoring of the status of cryopreserved samples and could lead in the future to automated monitoring of all biobank samples. Importantly, he has shown that it would be possible to take a fingerprint spectrum of every freshly preserved sample and use it as a reference to periodically confirm sample integrity during storage and upon eventual release."

Biobanks rely on the fact that aqueous samples are considered to be stably cryopreserved upon cooling to below -137°C, as this is the glass transition temperature (Tg) of amorphous water and ice crystal formation should not occur below Tg. Furthermore, chemical and biological activity and diffusion virtually stop below this temperature. If ice forms in vitrified samples due to transient infringing of the Tg, loss of the complete sample will follow. Mechanical and thermal incidents are possible in biobanking practice, for example when moving single specimens or entire sample collections, but are not detectable before rewarming.

The iDus series is the camera of choice for routine UV-Vis-NIR spectroscopy measurements, as well as more advanced, low light detection applications. The camera boasts sensor QE up to 95%, state-of-the-art Ultravac™, cooling down to -100°C, and a range of 1024 x 127 and 1024 x 256 CCD matrix with UV to NIR optimised options. Andor's modular Spectroscopy solutions encompass a wide range of high performance CCD, ICCD, EMCCD and InGaAs array detectors, as well as a comprehensive range of Research-grade spectrograph platforms. To learn more about the iDus camera series, please visit the Andor website [http://www.andor.com].

Reference

1. Daniel Dorr, Frank Stracke, and Heiko Zimmermann "Noninvasive Quality Control of Cryopreserved Samples," Biopreservation and Biobanking Vol. 10, No. 6, 529-531 (2012)

About Andor

Andor is a world leader in Scientific Imaging, Spectroscopy Solutions and Microscopy Systems. Established in 1989 from Queen's University in Belfast, Northern Ireland, Andor Technology now employs over 340 people in 16 offices worldwide, distributing its portfolio of over 70 products to 10,000 customers in 55 countries.

Andor’s digital cameras, designed and manufactured using pioneering techniques developed in-house, allow scientists around the world to measure light down to a single photon and capture events occurring within 1 billionth of a second. This unique capability is helping them push back the boundaries of knowledge in fields as diverse as drug discovery, toxicology analysis, medical diagnosis, food quality testing and solar energy research. More information about Andor Technology PLC (LSE: AND) is available at the company's website [www.andor.com].

For further information, please contact Andor Technology direct or their marketing agency, Catalyst Communications.

Andor Technology plc.

Corporate Headquarters

7 Millennium Way

Springvale Business Park

Belfast BT12 7AL

+44 (0) 28 9027 0812

Andor website

press@andor.com

Catalyst Communications

The Annexe

2 Crispin Way

Farnham Common

Buckinghamshire SL2 3UE

+44 (0) 1753 648 140

john.waite@catalystpr.com


Read at BioSpace.com

Andor
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->